Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now? Sunad RangarajanMorgan L. LocyVictor J. Thannickal Current Opinion 04 January 2016 Pages: 291 - 300
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease Lidia BakotaRoland Brandt Leading Article Open access 04 January 2016 Pages: 301 - 313
What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion Working Group Nientemale DEIR. VellucciP. Romualdi Therapy in Practice Open access 11 January 2016 Pages: 315 - 330
Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy Nick van EsSuzanne M. BlekerMarcello Di Nisio Review Article 04 January 2016 Pages: 331 - 341
Inhaled Umeclidinium in COPD Patients: A Review and Meta-Analysis Roy A. PleasantsTiansheng WangJames F. Donohue Review Article 11 January 2016 Pages: 343 - 361
Insulin Glargine 300 U/mL: A Review in Diabetes Mellitus Hannah A. BlairGillian M. Keating Adis Drug Evaluation 28 January 2016 Pages: 363 - 374
Pembrolizumab: A Review in Advanced Melanoma Emma D. Deeks Adis Drug Evaluation 04 February 2016 Pages: 375 - 386
Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction Paul L. McCormack Adis Drug Evaluation 12 February 2016 Pages: 387 - 396
Elotuzumab: First Global Approval Anthony Markham AdisInsight Report 26 January 2016 Pages: 397 - 403
Selexipag: First Global Approval Lesley J. Scott AdisInsight Report 04 February 2016 Pages: 413 - 418
Erratum to: Cariprazine: First Global Approval Paul L. McCormack Erratum 03 February 2016 Pages: 419 - 419